Glaucoma:

Indications for ROCKLATAN:

Open-angle glaucoma. Ocular hypertension.

Adult:

Instill 1 drop into the affected eye(s) once daily in the PM.

Children:

Not established.

Warnings/Precautions:

Do not exceed recommended dose. Ocular inflammation; avoid if active. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Herpetic keratitis; avoid if active. Concurrent corneal disease or disruption of the ocular epithelial surface. Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

Pharmacologic Class:

Rho kinase inhibitor + prostaglandin analogue.

Interactions:

Allow at least 5mins between application of thimerosal-containing oph drops or other topical oph agents. Concomitant additional prostaglandins or prostaglandin analogues: not recommended.

Adverse Reactions:

Conjunctival hyperemia, instillation site pain, corneal verticillata, conjunctival hemorrhage, eye pruritus, reduced visual acuity, increased lacrimation, instillation site discomfort, blurred vision; increased ocular pigmentation (eg, iris, eyelid, eyelashes; may be permanent), eyelash changes, bacterial keratitis.

Generic Availability:

NO

How Supplied:

Soln—2.5mL

Pricing for ROCKLATAN

2.5ml of 0.02%/0.005% eye dropper (Qty: 1)
Appx. price $291
GoodRx